Regentis Biomaterials RGNT
NYSE RGNT
$1.82 +0.01 (+0.55%)
As of: Oct 1, 2026 · 3:49 PM EDT

Regentis Biomaterials (RGNT) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Regentis Biomaterials' Liabilities and Shareholders Equity was $9.35 million in Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Regentis Biomaterials came in at $7.62 million.

  • In earlier years, Liabilities and Shareholders Equity was $482,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 Regentis Biomaterials 1.05 Mn -7.90 Mn - 9.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.35 Mn
Dec 31, 2025 7.62 Mn
Dec 31, 2024 482,000.00
API Access

Regentis Biomaterials Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RGNT&period=max&api_key=YOUR_API_KEY